153 related articles for article (PubMed ID: 17662526)
1. Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317.
Eckert GP; Vardanian L; Rebeck GW; Burns MP
Neurosci Lett; 2007 Aug; 423(1):47-52. PubMed ID: 17662526
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
[TBL] [Abstract][Full Text] [Related]
4. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
[TBL] [Abstract][Full Text] [Related]
5. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
6. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol independent effect of LXR agonist TO-901317 on gamma-secretase.
Czech C; Burns MP; Vardanian L; Augustin A; Jacobsen H; Baumann K; Rebeck GW
J Neurochem; 2007 May; 101(4):929-36. PubMed ID: 17472585
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
Qiu G; Hill JS
J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
[TBL] [Abstract][Full Text] [Related]
9. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
[TBL] [Abstract][Full Text] [Related]
10. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).
Menke JG; Macnaul KL; Hayes NS; Baffic J; Chao YS; Elbrecht A; Kelly LJ; Lam MH; Schmidt A; Sahoo S; Wang J; Wright SD; Xin P; Zhou G; Moller DE; Sparrow CP
Endocrinology; 2002 Jul; 143(7):2548-58. PubMed ID: 12072387
[TBL] [Abstract][Full Text] [Related]
11. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
Wong J; Quinn CM; Brown AJ
Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
[TBL] [Abstract][Full Text] [Related]
12. OSBP negatively regulates ABCA1 protein stability.
Bowden K; Ridgway ND
J Biol Chem; 2008 Jun; 283(26):18210-7. PubMed ID: 18450749
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
14. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux.
Abildayeva K; Jansen PJ; Hirsch-Reinshagen V; Bloks VW; Bakker AH; Ramaekers FC; de Vente J; Groen AK; Wellington CL; Kuipers F; Mulder M
J Biol Chem; 2006 May; 281(18):12799-808. PubMed ID: 16524875
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system.
Whitney KD; Watson MA; Collins JL; Benson WG; Stone TM; Numerick MJ; Tippin TK; Wilson JG; Winegar DA; Kliewer SA
Mol Endocrinol; 2002 Jun; 16(6):1378-85. PubMed ID: 12040022
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages.
Ayaori M; Sawada S; Yonemura A; Iwamoto N; Ogura M; Tanaka N; Nakaya K; Kusuhara M; Nakamura H; Ohsuzu F
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):163-8. PubMed ID: 16254209
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression.
Gentili C; Tutolo G; Pianezzi A; Cancedda R; Descalzi Cancedda F
Matrix Biol; 2005 Feb; 24(1):35-44. PubMed ID: 15749000
[TBL] [Abstract][Full Text] [Related]
18. N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.
Molteni V; Li X; Nabakka J; Liang F; Wityak J; Koder A; Vargas L; Romeo R; Mitro N; Mak PA; Seidel HM; Haslam JA; Chow D; Tuntland T; Spalding TA; Brock A; Bradley M; Castrillo A; Tontonoz P; Saez E
J Med Chem; 2007 Aug; 50(17):4255-9. PubMed ID: 17665897
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
20. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants.
Katz A; Udata C; Ott E; Hickey L; Burczynski ME; Burghart P; Vesterqvist O; Meng X
J Clin Pharmacol; 2009 Jun; 49(6):643-9. PubMed ID: 19398602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
